--- title: "US IPO Week Ahead: Advisory firm Lincoln International set to follow a hot week for IPOs" type: "News" locale: "en" url: "https://longbridge.com/en/news/286622978.md" description: "Lincoln International is set to raise $400 million at a $2 billion market cap in the upcoming IPO week, following a strong performance in client revenues. Additionally, Conexeu Sciences plans a direct listing on Nasdaq with a market cap of $120 million. The IPO market shows positive trends, with the Renaissance IPO Index up 10.8% year-to-date." datetime: "2026-05-15T23:07:21.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286622978.md) - [en](https://longbridge.com/en/news/286622978.md) - [zh-HK](https://longbridge.com/zh-HK/news/286622978.md) --- # US IPO Week Ahead: Advisory firm Lincoln International set to follow a hot week for IPOs One IPO and one direct listing are currently scheduled to list in the week ahead, although some smaller issuers may also join the calendar throughout the week. Investment banking advisory firm **Lincoln International** (LCLN) is set to raise $400 million at a $2.0 billion market cap. Lincoln International is a global independent investment banking advisory firm focused on the private capital markets, focused on advising private equity and private credit investors, private company business owners, and other senior executives. The company provides private capital markets expertise across two segments: Investment Banking Advisory, and Valuations and Opinions. Lincoln International boasts a 16% CAGR for client revenues from 2015 to pro forma 2025, but its peers have posted weak trading among geopolitical and private credit concerns. Medical device developer **Conexeu Sciences** (CNXU) plans to complete a direct listing on the Nasdaq. Based on its March 2026 private placement, the company would command a market cap of $120 million. Conexeu states that it has developed a proprietary platform built around a patented device candidate; CXU Scaffold, an extra cellular matrix (ECM) scaffold designed to support the body's natural regenerative processes. This platform leverages a temperature-sensitive collagen-based solution that becomes a gel-like scaffold upon injection or application in the body, typically within about ten minutes. The company is conducting preclinical research for its device to be used as an injectable soft-tissue filler for facial indications, as well as wound care. Street research is expected for five companies in the week ahead, and three lock-up periods will be expiring. For access to Street research and lock-up expiration dates, sign up for a free trial of IPO Pro. **IPO Market Snapshot **The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 5/14/2026, the Renaissance IPO Index was up 10.8% year-to-date, while the S&P 500 was up 10.0%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include CoreWeave (CRWV) and Astera Labs (ALAB). The Renaissance International IPO Index was up 27.4% year-to-date, while the ACWX was up 12.6%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Kioxia and Galderma. ### Related Stocks - [IPO.US](https://longbridge.com/en/quote/IPO.US.md) - [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md) - [CRWV.US](https://longbridge.com/en/quote/CRWV.US.md) - [ALAB.US](https://longbridge.com/en/quote/ALAB.US.md) - [ACWX.US](https://longbridge.com/en/quote/ACWX.US.md) - [IPOS.US](https://longbridge.com/en/quote/IPOS.US.md) ## Related News & Research - [IPO Weekly Weigh-in: AI and lottery ticket IPOs?](https://longbridge.com/en/news/287074191.md) - [Cerebras IPO Euphoria Sends CBRS Stock Into Rare Air](https://longbridge.com/en/news/286763495.md) - [1 surprising way Oklo could benefit from the looming SpaceX IPO](https://longbridge.com/en/news/286652457.md) - [Blackstone Has a New Data Center REIT. Its BXDC IPO Might Be a Little Too Late.](https://longbridge.com/en/news/286430885.md) - [SpaceX IPO: 3 scenarios for what a $5,000 investment could be worth by 2030](https://longbridge.com/en/news/286642151.md)